Mandate

Vinge advises Bygghemma in connection with acquisition of Hemfint

February 26, 2020

Vinge has advised Bygghemma Sverige AB in connection with the acquisition of 84 per cent of the shares in Hemfint Kristianstad AB for a fixed purchase price regarding 51 per cent of the shares, an earn-out based purchase price regarding 33 per cent of the shares over a 3-year period as well as an option to acquire the remaining shares within 3-4 years.

Bygghemma is the leading online based European supplier of products and services within DIY and home furnishings. In 2019, Bygghemma’s turnover was SEK 6.2 billion and the company employs more than 1 500 persons, has its head office in Malmö and is listed on Nasdaq Stockholm, Mid Cap. Hemfint is a fast-growing online provider of doors, windows, bathroom and leisure products in Sweden under its own trademarks and had a turnover of more than SEK 150 million in 2018.

Vinge’s team consisted of partner Kristian Ford together with, among others, associates Niklas Törnell, Tilda Hall, Jessica Salomonsson (commercial property/real estate) and Freja Najafi Kristensen (employment). 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026